The Dividend Yield as of December 2024 (TTM) for Enanta Pharmaceuticals, Inc. (ENTA) is 0%

According to Enanta Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Enanta Pharmaceuticals, Inc. (ENTA) Historical Dividend Yield (quarterly & annually)

How has ENTA Dividend Yield performed in the past?

The mean historical Dividend Yield of Enanta Pharmaceuticals, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), ENTA's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.

Enanta Pharmaceuticals, Inc. (ENTA) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Enanta Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Enanta Pharmaceuticals, Inc. (ENTA) Average Dividend Yield

How has ENTA Dividend Yield performed in the past?

The current Dividend Yield of Enanta Pharmaceuticals, Inc. (ENTA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Enanta Pharmaceuticals, Inc. (ENTA) Dividend Yield vs. Peers

How is ENTA’s Dividend Yield compared to its peers?

Enanta Pharmaceuticals, Inc.’s Dividend Yield is less than Monte Rosa Therapeutics, Inc. (0%), less than Design Therapeutics, Inc. (0%), less than Werewolf Therapeutics, Inc. (0%), less than Ikena Oncology, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Crinetics Pharmaceuticals, Inc. (0%), less than Inhibrx Biosciences, Inc. (5.87%), less than Merus N.V. (0%), less than Lyell Immunopharma, Inc. (0%), less than Kronos Bio, Inc. (0%), less than Century Therapeutics, Inc. (0%), less than Edgewise Therapeutics, Inc. (0%), less than C4 Therapeutics, Inc. (0%), less than Mineralys Therapeutics, Inc. (0%), less than Cullinan Oncology, Inc. (0%), less than Theseus Pharmaceuticals, Inc. (0%), less than Revolution Medicines, Inc. (0%),

Build a custom stock screener for Enanta Pharmaceuticals, Inc. (ENTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enanta Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enanta Pharmaceuticals, Inc. (ENTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enanta Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.